OKLO heads into late June with its short thesis unwinding at the edges — yet the lending market and insider activity both tell a more complicated story.
Short interest has pulled back meaningfully from its May peak. Bears held roughly 28% of the free float in late May; that figure has eased to 17.1%, a 7.5% decline over the past month. The direction is clear. But 17% short interest is still elevated for a pre-revenue nuclear startup, and the retreat looks more like a steady bleed than capitulation. Shorts are lightening up, not clearing out.
The lending market reflects that lingering caution. Availability ran as tight as 5.5% in late May — nearly every share in the borrow pool was already lent out. It has since loosened to around 49%, a sharp reversal but still well within the tight range. Cost to borrow, meanwhile, has fallen more than 30% over the past week to just 0.73%, its lowest level in the trailing 30-day window. That combination — more shares available and cheaper to borrow — removes the short-squeeze tension that characterized May's setup. Options traders have shifted in the same direction: the put/call ratio dropped to 0.62, nearly 1.6 standard deviations below its 20-day average of 0.66. Call positioning is running well above recent norms, suggesting options buyers have tilted decisively toward upside exposure even as the stock slipped 2% on Tuesday and is roughly flat on the week.
The Street picture is split, and the valuation doesn't resolve the debate. Most analysts who have initiated coverage in recent weeks landed at Neutral — JPMorgan opened with an $83 target in mid-May, Wolfe Research came in at Peer Perform with no target, and UBS's Jon Windham trimmed his target to $55 (below the current $57.19 price) as recently as June 11, the freshest move in the dataset. The bulls are louder but fewer: Cantor Fitzgerald holds at $122, Wedbush reiterates Outperform at $110, and HSBC initiated at Buy with a $96 target. The consensus mean of $88.63 implies roughly 55% upside — but that figure is pulled hard by a handful of high-conviction bulls. Price-to-book has compressed from above 5.8x a month ago to 4.0x today, reflecting both the stock's 13% decline over the past month and some recalibration of the speculative premium. ORTEX factor scores add color: the short-score rank is in the 5th percentile, meaning OKLO sits among the most-shorted names in the universe, while the EPS surprise rank at 67 is relatively strong for a pre-revenue name.
The insider tape from June 1 is worth noting. CEO and co-founder Jacob DeWitte sold roughly 100,000 shares across several transactions totaling over $6.9 million. COO Caroline Cochran sold approximately 74,800 shares for just under $4.1 million. CFO Richard Bealmear added another $5 million in sales. The three founders collectively reduced exposure by more than $16 million on a single day — at prices around $65–70, well above the current $57.19. Their remaining holdings are still substantial — DeWitte holds roughly 2.65 million shares, Cochran 2.01 million — but the timing and scale of the sales register against a backdrop of a stock that has since fallen 13% from those levels.
Earnings history adds a further note of caution. The most recent print in early June produced a 1-day decline of 11% and a 5-day decline of 26%. The prior result in May tracked almost identically — down 10.8% on day one, down 28.5% by day five. The next scheduled event is August 12. Between now and then, what matters most is whether the short-covering trend continues and whether the recent loosening in borrow availability hardens into a structural shift — or reverses as the earnings window approaches.
See the live data behind this article on ORTEX.
Open OKLO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
